🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Goldman Sachs sets target on Accenture shares, rating Neutral

EditorAhmed Abdulazez Abdulkadir
Published 06/24/2024, 05:28 AM
© Reuters.
ACN
-

On Monday, Goldman Sachs initiated coverage on shares of Accenture plc (NYSE:ACN) with a Neutral rating and a price target set at $335.00. The firm acknowledges Accenture as the world's leading IT Services provider, particularly highlighting its top-tier generative AI capabilities, which are expected to secure a substantial portion of business partnerships.

The firm's statement recognized the potential challenges facing Accenture, citing the possibility of cyclical economic headwinds that may impact the company's Operations and Commercial Applications Development sectors over the next six months. These headwinds are seen as temporary obstacles that could affect the company's performance in the short term.

Despite these concerns, Goldman Sachs anticipates significant secular growth opportunities for Accenture once the current economic headwinds have diminished. The firm suggests that while Accenture is poised to benefit from these long-term trends, there may be more advantageous moments to invest in the company's stock.

The price target of $335.00 reflects Goldman Sachs' assessment of Accenture's value, considering both the immediate challenges and the company's strong position in the field of generative AI. This valuation serves as a benchmark for investors monitoring Accenture's stock performance.

Accenture's role as a preferred partner in the IT Services industry, especially in the realm of generative AI, is expected to contribute to its long-term success and market share growth. However, the current cyclical challenges are noted as factors that investors should consider when evaluating the timing of their investment decisions.

In other recent news, Accenture has reported steady growth and strategic investments in its Third Quarter Fiscal 2024 Earnings Conference Call. The company disclosed a revenue of $16.5 billion, marking a 1.4% increase in local currency, and an operating margin improvement to 16.4%. New bookings saw a substantial increase, totaling $21.1 billion, a growth of 22% in US dollars and 26% in local currency. Notably, Accenture's GenAI business has reached $2 billion in sales year-to-date, highlighting the company's focus on large-scale transformations, especially in artificial intelligence.

In the same vein, the company made 12 acquisitions, amassing a capital investment of $2.3 billion. Despite a minor 1% decline in revenue in US dollars, Accenture projects its Q4 fiscal 2024 revenue to be between $16.05 billion and $16.65 billion, indicating 2% to 6% growth in local currency. The full fiscal year 2024 growth is expected to be between 1.5% and 2.5% in local currency, with operating cash flow forecasted to be between $9.3 billion and $9.9 billion.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.